ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

FLX vs TMO // 10Y YIELD & FRED MACRO BETA

BingEx Limited (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: FLX 4 — TMO 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FLX VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC FLX TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 11.80% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 13.30% 9.30% +4.00 FLX /roic <GO>
EV/EBITDA & P/E Valuation 8.1x 30.4x -22.30 FLX /valuation <GO>
Free Cash Flow Yield 13.16% 2.40% +10.76 FLX /fcf-yield <GO>
Operating Margin 1.20% 17.40% -16.20 TMO /operating-margins <GO>
Net Profit Margin 2.70% 15.10% -12.40 TMO /net-margins <GO>
Revenue Growth (YoY) -6.70% 3.90% -10.60 TMO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.10 4.50 -2.40 TMO /balance-sheet <GO>
Piotroski F-Score Quality 5/9 8/9 -3.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.6 62.9 -14.33 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 6.4x 36.3x -29.90 FLX /forward-pe <GO>
Enterprise Scale & Market Cap $107.5M $262.22B -$262.11B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR FLX REV TMO REV FLX GROSS % TMO GROSS % FLX FCF TMO FCF
FY 2025 $570.9M $44.56B 11.8% — $14.1M $6.29B
FY 2024 $612.1M $42.88B 11.0% — $144.0K $7.27B
FY 2023 — $42.86B — — — $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FLX // BETA —
TMO // BETA 0.94